1-3 of 3
Sarah-Jane Bull
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Economic Impact of Treatment Sequencing in the Management of Chronic Lymphocytic Leukemia in Canada Using Venetoclax Plus Obinutuzumab

Kimberly Guinan, Jean Lachaine, Nancy Paul Roc, Sarah-Jane Bull, Dipti Tankala, Stéphane Barakat, Christopher M. Hillis, Versha Banerji
Journal: Blood
Blood (2022) 140 (Supplement 1): 2157–2158.
https://doi.org/10.1182/blood-2022-167235
Published: 2022
Journal Articles

Quality of Life in Patients with Chronic Lymphocytic Leukemia Initiating Venetoclax in Routine Clinical Practice across Canada: Results from the Devote Study

Andrew Aw, Versha Banerji, Sarah-Jane Bull, Pierre-André Fournier, Anthea Peters, Carolyn Owen
Journal: Blood
Blood (2022) 140 (Supplement 1): 12425–12426.
https://doi.org/10.1182/blood-2022-156749
Published: 2022
Journal Articles

Tumor Lysis Syndrome: Incidence, Mitigation and Management in Patients with Chronic Lymphocytic Leukemia Initiating Venetoclax in Routine Clinical Practice (DEVOTE) across Canada

Versha Banerji, Nizar Abdel-Samad, Andrew Aw, Sarah-Jane Bull, Pierre-André Fournier, Nathalie Johnson, Nicole B. Laferriere, Paola Lembo, Christina H Pelizon, Anthea Peters, Carolyn Owen
Journal: Blood
Blood (2021) 138 (Supplement 1): 3744.
https://doi.org/10.1182/blood-2021-146001
Published: 2021